Literature DB >> 2904976

Neuroleptic malignant syndrome in a patient with Wilson's disease.

V Kontaxakis, C Stefanis, M Markidis, V Tserpe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2904976      PMCID： PMC1033212          DOI： 10.1136/jnnp.51.7.1001

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Lithium carbonate, haloperidol, and irreversible brain damage.

Authors:  W J Cohen; N H Cohen
Journal:  JAMA       Date:  1974-12-02       Impact factor: 56.272

2.  Neuroleptic malignant syndrome. Successful treatment with bromocriptine.

Authors:  P S Mueller; J W Vester; J Fermaglich
Journal:  JAMA       Date:  1983-01-21       Impact factor: 56.272

3.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

4.  Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.

Authors:  A R Eiser; M S Neff; R F Slifkin
Journal:  Arch Intern Med       Date:  1982-03

5.  Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Authors:  V W Henderson; G F Wooten
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

6.  Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.

Authors:  R E Burke; S Fahn; R Mayeux; H Weinberg; K Louis; J H Willner
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

7.  The neuroleptic malignant syndrome.

Authors:  S N Caroff
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384

8.  Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.

Authors:  H G Pope; P E Keck; S L McElroy
Journal:  Am J Psychiatry       Date:  1986-10       Impact factor: 18.112

Review 9.  The neuroleptic malignant syndrome: agent and host interaction.

Authors:  A Shalev; H Munitz
Journal:  Acta Psychiatr Scand       Date:  1986-04       Impact factor: 6.392
  9 in total
  1 in total

Review 1.  Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Authors:  Tomasz Litwin; Petr Dusek; Tomasz Szafrański; Karolina Dzieżyc; Anna Członkowska; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.